Critical Advances in Mitigating Progression of Diabetic Eye Disease
Glucose Monitoring in the Managed Care Pharmacy and Medical Setting
Combination Therapy with DTE in Appropriately Selected Patients with Hypothyroidsm
The Diabetes and Primary Care Specialist's Perspective on PREVENTING "INEVITABLE" BLINDNESS in the PATIENT with DIABETES
Optimizing the Use of Sensor-Based Glucose Monitoring in the Primary Care Setting
Critical Advances in Flash-Based CGM: A Foundational Approach to Optimizing Health Metrics and Costs Across the Entire Spectrum of Diabetes Care
Preventing "Inevitable" Blindness in the Diabetic Patient
Translating Trial-Based Evidence and Real World Data for Sensor-Based Glucsose Monitoring
Trial-Based Evidence and Real World Data for Sensory-Based Glucose Monitoring at the Front Lines of Diabetes Care
Combination Therapy with DTE in Appropriately Selected Patients with Hypothyroidsm
Sensor-Based CGM Across the Diabetes Treatment Spectrum
The Optometrist's Critical Role in Screening, Diagnosis, and Refrerring Patients with Diabetic Retinopathy
The Optometrist's Critical Role in Screening, Diagnosis, and Refrerring Patients with Diabetic Retinopathy
Clinical Evidence for Sensor-Based Glucose Monitoring and Technological Innovations
Sensor-Based Glucose Monitoring to the Front Lines of Pharmacy Management
Interpretation of Sensor-Based Glucose Metrics, Time in Range (TIR) and Ambulatory Glucose Profiles (AGP)
Technological Innovations in Sensor-Based Glucose Monitoring
PCSK9 Inhibition in the Diabetic Patient
Fixed-Ratio Combination Basal Insulin plus GLP-1 RA Regimens
Complementary Insulin Combinations to Optimize Glycemic Control in T2D
Translating Clinical Evidence for Sensor-Based Glucose Monitoring and Technological Innovations
Basal Insulin in Vulnerable Patients with Type 2 Diabetes Technology-Based Innovations in Continuous Glucose Monitoring (CGM)
CV Risk Reduction and Glycemic Control in T2D
Translating Clinical Evidence for Sensor-Based Glucose Monitoring and Technological Innovations to the Front Lines of Clinical Practice
Optimizing Comprehensive Care and Referral Strategies for the Optometrist Navigating the Complex Maze of LDL-Lowering Therapies
Physiologic, Ultra-Long-Acting Basal insulin in Vulnerable Patients with T2D
The Importance of Early Diagnosis, Testing, and Recognition of Unusual and Heterogeneous Symptoms of Fabry Disease
From Landmark CV Outcome Trials to the Front Lines of ASCVD Risk Reduction — Lipid Medicine and Antherosclerosis Prevention
From Landmark CV Outcome Trials to the Front Lines of ASCVD Risk Reduction — Medical and Preventive Cardiology
From Landmark CV Outcome Trials to the Front Lines of ASCVD Risk Reduction

​

We are pleased to inform healthcare providers from all specialties who have accessed this site that the University of Massachusetts Medical School, Office of Continuing Education, is a principal provider of joint sponsorship for CME programming on ClinicalWebcasts.com and associated sites.

From Landmark CV Outcome Trials to the Front Lines of ASCVD Risk Reduction - Program 4 in a  four-part series

 cme